Valneva

Valneva is a specialty vaccine company focused on the development and commercialization of preventive vaccines for infectious diseases with significant unmet medical needs. We adopt a highly specialized and targeted approach to vaccine development, first identifying fatal and debilitating infectious diseases that lack preventive vaccine solutions and have limited treatment options. We then apply our deep understanding of vaccine science, including our expertise in multiple vaccine platforms, as well as our established vaccine development capabilities, to develop preventive vaccines to address these diseases. Leveraging our expertise and capabilities, we have successfully commercialized two vaccines and rapidly advanced multiple vaccine candidates into and through clinical trials, including candidates for Lyme disease, chikungunya virus, and COVID-19. Our clinical portfolio consists of several highly differentiated vaccine candidates aimed at providing preventive solutions for diseases with high unmet needs.